Relationship between peripheral B cell return and loss of EULAR response in RA patients treated with rituximab.

被引：0
|
作者：
Emery, P.
Breedveld, F.
Martin-Mola, E.
Pavelka, K.
Szczepanski, L.
Kim, D.
Magrini, F.
Behrendt, C.
Kelman, A.
机构：
[1] Leeds Gen Infirm, Leeds, W Yorkshire, England
[2] Leiden Univ, Leiden, Netherlands
[3] Hosp Univ La Paz, Madrid, Spain
[4] Inst Rheumatol, Prague, Czech Republic
[5] Tech Univ Lublin, PL-20618 Lublin, Poland
[6] Biogen Idec, San Diego, CA USA
[7] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[8] Genentech Inc, San Francisco, CA 94080 USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] Relationship between peripheral B cell levels and loss of EULAR response in rheumatoid arthritis patients treated with rituximab
    Emery, P.
    Breedveld, F.
    Martin-Mola, E.
    Pavelka, K.
    Szczepanski, L.
    Hagerty, D.
    Magrini, F.
    Behrendt, C.
    Kelman, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 124 - 124
  • [2] Response to immunization in SLE patients treated with rituximab.
    Albert, Daniel A.
    Moldovan, Amir
    Barnack, Felicia
    Loh, Louise
    Eisenberg, Robert A.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S550 - S550
  • [3] Relationship between clinical response, rituximab (RTX) pharmacokinetics, and peripheral B cell levels in rheumatoid arthritis (RA).
    Breedveld, F.
    Agarwal, S.
    Yin, M.
    Ng, C.
    Li, N.
    Shaw, T.
    Davies, B.
    [J]. CLINICAL IMMUNOLOGY, 2006, 119 : S64 - S65
  • [4] PREDICTIVE FACTORS FOR THE EULAR RESPONSE IN RA PATIENTS WITH RITUXIMAB TREATMENT
    Peltea, Alexandra
    Mazilu, Diana
    Gudu, Tania
    Opris, Daniela
    Ionescu, Ruxandra
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A2 - A2
  • [5] Combination of B cell biomarkers as independent predictors of response in patients with RA treated with rituximab
    Tony, H-P.
    Roll, P.
    Mei, H. E.
    Bluemner, E.
    Straka, A.
    Gnuegge, L.
    Doerner, T.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (06) : 887 - 894
  • [6] Primary cutaneous large B cell lymphoma of the legs treated with rituximab.
    Aboulafia, DM
    [J]. BLOOD, 1999, 94 (10) : 257B - 257B
  • [7] Relationship between clinical response, rituximab pharmacokinetics and peripheral B cell levels in rheumatoid arthritis
    Breedveld, F. C.
    Agarwal, S.
    Yin, M.
    Ng, C.
    Li, N. F.
    Shaw, T. M.
    Davies, B. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 179 - 179
  • [8] Relationship between clinical response, rituximab pharmacokinetics, and peripheral B cell levels in rheumatoid arthritis.
    Breedveld, FC
    Agarwal, S
    Yin, M
    Ng, C
    Li, NF
    Sewell, KL
    Shaw, TM
    Davies, BE
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S138 - S138
  • [9] Value of Predictive B Cell Markers for EULAR Response to RITUXIMAB in Patients with Rheumatoid Arthritis (FIRST)
    Tony, Hans-Peter
    Roll, Petra
    Mei, Henrik
    Gnuegge, Lara
    Kobialko, Monika
    Doerner, Thomas
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S682 - S682
  • [10] Response to rituximab therapy in RA correlates with variable B cell expression in peripheral blood and synovium
    Dass, S.
    Coulthard, L.
    Rawstron, A. C.
    English, A.
    Vital, E. M.
    Reece, R.
    Bingham, S. J.
    McDermott, M.
    Emery, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 186 - 186
12345